Compare ADAG & OPBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADAG | OPBK |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | China | United States |
| Employees | 128 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.2M | 230.9M |
| IPO Year | 2020 | 2018 |
| Metric | ADAG | OPBK |
|---|---|---|
| Price | $3.25 | $15.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $8.25 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 192.3K | 33.1K |
| Earning Date | 04-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.73% |
| EPS Growth | N/A | ★ 23.74 |
| EPS | N/A | ★ 1.02 |
| Revenue | N/A | ★ $3,204,000.00 |
| Revenue This Year | N/A | $16.07 |
| Revenue Next Year | N/A | $11.60 |
| P/E Ratio | ★ N/A | $15.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.44 | $12.41 |
| 52 Week High | $4.85 | $16.83 |
| Indicator | ADAG | OPBK |
|---|---|---|
| Relative Strength Index (RSI) | 41.48 | 49.50 |
| Support Level | $3.23 | $13.57 |
| Resistance Level | $3.53 | $15.61 |
| Average True Range (ATR) | 0.28 | 0.29 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 34.95 | 54.30 |
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.
OP Bancorp operates its commercial community banking activities through Open Bank its wholly owned banking subsidiary. It provides commercial banking services to small and medium-sized businesses, their owners, and retail customers, with a focus on the Korean-American community. The bank currently operate twelve full service branches: nine branches across Los Angeles and Orange Counties in California, as well as one branch each in Santa Clara, California; Carrollton, Texas; and Las Vegas, Nevada. Additionally, it maintains five loan production offices located in Pleasanton, California; Atlanta, Georgia; Aurora, Colorado; Lynnwood, Washington; and Fairfax, Virginia. Substantially all its business activities are conducted through the Bank.